HA-HIF1a (S668A)
(Plasmid
#49463)
-
PurposeHA-tagged HIF-1a Ser668 resuide mutated to Ala
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 49463 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3
-
Backbone manufacturerinvitrogen
- Backbone size w/o insert (bp) 5433
- Total vector size (bp) 7938
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHypoxia inducible factor 1 alpha
-
Alt nameHIF-1a
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2505
-
MutationSerine 668 to Alanine
-
GenBank IDNM_001530
-
Entrez GeneHIF1A (a.k.a. HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78)
- Promoter T7
-
Tag
/ Fusion Protein
- HA (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH1 (unknown if destroyed)
- 3′ cloning site ECOR1 (unknown if destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer SP6 (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAddgene Plasmid 18949: HA-HIF1alpha-pcDNA3
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
HA-HIF1a (S668A) was a gift from Wafik El-Deiry (Addgene plasmid # 49463 ; http://n2t.net/addgene:49463 ; RRID:Addgene_49463) -
For your References section:
CDK1 stabilizes HIF-1alpha via direct phosphorylation of Ser668 to promote tumor growth. Warfel NA, Dolloff NG, Dicker DT, Malysz J, El-Deiry WS. Cell Cycle. 2013 Oct 25;12(23). 10.4161/cc.26930 PubMed 24189531